Skip to main content

Raiffeisen Bank International AG

Bank

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 2044885 VIENNA, C4

Position in IOVA

as of Mar 31, 2026 · filed Apr 24, 2026
Position Value
$1,333,800
+$105,300 QoQ
Shares Held
380,000
-15.6% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Mar 31, 2026
CallValue
$7,020
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Raiffeisen Bank International AG holds $97,826,369 across 28 Biotechnology names. IOVA ranks #12 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,333,800 380,000
2026-03-31 $7,020 2,000
2025-12-31 $1,228,500 450,000
2025-12-31 $5,460 2,000
2025-09-30 $520,800 240,000
2025-09-30 $4,340 2,000
2025-06-30 $252,840 147,000
2025-03-31 $489,510 147,000
2024-12-31 $754,800 102,000